Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Neurodiagnostics Market Grown from 2024 to 2025?

The market for neurodiagnostics has experienced robust growth over recent years. The market value, which sits at $9.17 billion as of 2024, is projected to rise to $9.82 billion in 2025, with a compound annual growth rate (CAGR) of 7.1%. This historical growth is largely due to an increase in neurological disorders, heightened uptake of cutting-edge imaging technologies, growth of the elderly demographic, awareness of the importance of early disease diagnosis, expanding healthcare infrastructure, and increased financial investments in neuroscience research and development.

What Growth Rate Is Anticipated for the Neurodiagnostics Market in the Coming Years?

The size of the neurodiagnostics market is forecasted to experience robust growth in the approaching years. The market is set to expand to $12.79 billion by 2029, with a compound annual growth rate (CAGR) of 6.8%. The surge in growth during the forecast period can be traced back to factors such as the increased demand for non-invasive diagnostic methods, a higher occurrence of neurological disorders, increased investment in healthcare infrastructure by the government, raising awareness and initiatives for early detection, and the broadening scope of personalized medicine. Significant trends predicted for this period include the creation of more portable EEG devices, incorporation of AI for heightened diagnostic precision, advanced MRI technologies for brain imaging, utilisation of wearables for constant monitoring, advancements in neurogenetic testing, and the implementation of real-time data analytics for bespoke treatment plans.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20902&type=smp

Who Are the Leading Companies in the Neurodiagnostics Market?

Major companies operating in the neurodiagnostics market are Nihon Kohden Corporation, Cephalon LLC, Stratus Neuro LLC, Cadwell Industries Inc., Compumedics Limited, Ceribell Inc., CND Life Sciences Inc., Lifelines Neuro Inc., ANT Neuro B.V., Neurovative Diagnostics LLC, Firefly Neuroscience Inc, IntraNerve Neuroscience Inc, NeuroDiagnostics Laboratories LLC, Advanced Brain Monitoring Inc, Spes Medica S.r.l., BioSignal Group Inc, Combinostics Inc., Deymed Diagnostic LLC, NeuLine Health Inc., Ridge Diagnostics Inc., Beacon Biosignals Inc., Intch Inc.

What Are the Key Drivers of the Neurodiagnostics Market?

The escalating occurrence of brain-related disorders is anticipated to propel the expansion of the neurodiagnostics market. Neurological disorders, which involve conditions influencing the brain, spinal cord or nerves, can lead to numerous cognitive, motor, and sensory disabilities. A surge in these disorders can be attributed to various factors such as aging populations, environmental influences, changes in lifestyle, genetics, and improved diagnostic techniques. Neurodiagnostics play a crucial role in the precise identification, assessment, and surveillance of these disorders. They facilitate accurate diagnoses, well-informed treatment choices, and efficient management of conditions involving the brain, spinal cord, and nerves. As an example, the National Library of Medicine, a US-based medical library for medical research information, reported in April 2023, that 6.7 million Americans were affected by Alzheimer’s in 2023, with the figure expected to climb to 13.8 million by 2060. Consequently, the escalating occurrence of neurological disorders is stimulating the expansion of the neurodiagnostics market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=20902&type=smp

What Are the Key Market Segments in the Neurodiagnostics Industry?

The neurodiagnostics market covered in this report is segmented –

1) By Type: Diagnostic And Imaging Solutions, In-Vitro Diagnostics

2) By Technology: Neuroimaging Technologies, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Nuclear Medicine Imaging (PET, SPECT), Near Infrared Spectroscopic Imaging (NIRS), Electro-Encephalography (EEG), Magneto-Encephalography (MEG), Voxel Based Morphometry (VBM), Neuroinformatics

3) By Condition: Epilepsy, Alzheimer’s Disease, Parkinson’s Disease, Stroke, Joint Health, Other Conditions

4) By End Use : Hospitals And Clinics, Diagnostic Laboratories, Imaging Centers, Other End Uses

Subsegments:

1) By Diagnostic And Imaging Solutions: MRI (Magnetic Resonance Imaging) Systems, CT (Computed Tomography) Scanners, EEG (Electroencephalogram) Systems, EMG (Electromyography) Systems, MEG (Magnetoencephalography) Systems, PET (Positron Emission Tomography) Scanners, SPECT (Single Photon Emission Computed Tomography) Scanners, Functional MRI (fMRI) Systems, Intracranial Pressure Monitors

2) By In-Vitro Diagnostics: Blood-Based Diagnostics, Cerebrospinal Fluid (Csf) Analysis, Genetic Testing And Biomarkers, Neurochemical Diagnostics, Point-Of-Care Neurodiagnostics, Diagnostic Kits For Neurodegenerative Disorders

What Are the Latest Trends in the Neurodiagnostics Market?

Leading firms in the field of neurodiagnostics are concentrating their efforts on technological innovations, with a particular focus on the development of advanced software algorithms. This push for innovative technology is aimed at boosting the precision of diagnoses and increasing patient recovery rates. The term “advanced software algorithm” refers to a complex series of instructions capable of processing and evaluating data using artificial intelligence (AI) or machine learning. This aids in enhancing decision-making processes and the overall diagnostic capabilities. A notable example of this can be seen in October 2023, when Ceribell Inc., a medical equipment manufacturing firm based in the US, unveiled its ClarityPro AI algorithm. This launch marked a significant milestone in the diagnosis of electrographic status epilepticus (ESE). This leading-edge software, when integrated into the Ceribell EEG system, uses machine learning to examine EEG waveforms and promptly provides alerts about potential seizure activity. It is especially noteworthy that ClarityPro is the first acute care device to receive FDA approval for autonomous diagnosis. This revolutionary technology is envisioned to refine clinical decision-making by continuously monitoring brain functions, providing key insights, and facilitating speedy and effective responses to treatment tactics.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/neurodiagnostics-global-market-report

What Are the Key Regional Markets in the Neurodiagnostics Industry?

North America was the largest region in the neurodiagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neurodiagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20902

This Report Delivers Insight On:

1. How big is the neurodiagnostics market, and how is it changing globally?

2. Who are the major companies in the neurodiagnostics market, and how are they performing?

3. What are the key opportunities and risks in the neurodiagnostics market right now?

4. Which products or customer segments are growing the most in the neurodiagnostics market?

5. What factors are helping or slowing down the growth of the neurodiagnostics market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model